Since the level of platinum in the environment is destined to increase, because of its use in vehicle catalytic converters, the toxicity of platinum needs further investigation. In this study, the frog embryo teratogenesis assay–Xenopus (FETAX) was used to compare the embryotoxicity and teratogenicity of two common platinum species, (NH4)2PtCl4 and (NH4)2PtCl6. The uptake rates of the two platinum species were studied, and also their effects on the expression of genes encoding metallothionein and heat-shock protein 70, which are known to be induced by several stress factors. In addition, the differential display technique was used to search for genes that were specifically induced by platinum. A gene for the type I collagen α-chain and a novel gene were identified.
HelmersE., & KuemmererK. (1999). Anthropogenic platinum fluxes: quantification of sources and sinks, and outlook. Environmental Science and Pollution Research International6, 29–36.
2.
GomezB., GomezM., SanchezJ.L., FernandezR., & PalaciosM.A. (2001). Platinum and rhodium distribution in airborne particulate matter and road dust. Science of the Total Environment269, 131–144.
3.
ArteltS., CreutzenbergO., KockH., LevsenK., NachtigallD., HeinrichU., RühleT., & SchlöglR. (1999). Bioavailability of fine dispersed platinum as emitted from automotive catalytic converters: a model study. Science of the Total Environment228, 219–242.
4.
RauchS., & MorrisonG.M. (1999). Platinum uptake by the freshwater isopod Asellus aquaticus in urban rivers. Science of the Total Environment235, 261–268.
5.
GietemaJ.A., MeinardiM.T., MesserschmidtJ., GelevertT., AltF., UgesD.R.A., & SleijferD.T. (2000). Circulating plasma platinum more than 10 years after cisplatin treatment for testicular cancer. Lancet355, 1075–1076.
6.
TravisL.B., HolowatyE.J., BergfeldtK., LynchC.F., KohlerB.A., WiklundT., CurtisR.E., HallP., AnderssonM., PukkalaE., SturgeonJ., StovallM., StormH., ClarkeE.A., BoiceJ.D.Jr., & GospodarowiczM. (1999). Risk of leukemia after platinum-based chemotherapy for ovarian cancer. New England Journal of Medicine340, 351–357.
7.
KümmererK., HelmersE., HubnerP., MascartG., MilandriM., ReinthalerF., & ZwakenbergM. (1999). European hospitals as a source for platinum in the environment in comparison with other sources. Science of the Total Environment225, 155–165.
8.
DumontJ., SchultzT.W., BuchananM., & KaoG. (1983). Frog embryo teratogenesis assay–Xenopus (FETAX): a short-term assay applicable to complex environmental mixtures. In Short-term Bioassays in the Analysis of Complex Environmental Mixtures (ed. WatersM.D., SandhuS.S., LewtasJ., ClaxtonL., ChernoffN., & NesnowS.), pp. 393–405. New York, NY, USA: Plenum Press.
9.
PratiM., GornatiR., BoracchiP., BiganzoliE., FortanerS., PietraR., SabbioniE., & BernardiniG. (2002). A comparative study of the toxicity of mercury dichloride and methylmercury, assayed by the frog embryo teratogenesis assay–Xenopus (FETAX). ATLA30, 23–32.
10.
KlassenC.D., LiuJ., & ChoudhurS. (1999). Metallothionein: an intracellular protein to protect against cadmium toxicity. Annual Review of Pharmacology and Toxicology39, 267–294.
11.
De MaioA. (1999). Heat shock proteins: facts, thoughts, and dreams. Shock11, 1–12.
12.
SakumaM. (1998). Probit analysis of preference data. Applied Entomology and Zoology33, 339–347.
13.
ConsalezG.G., CabibboA., CorradiA., AlliC., SardellaM., SitiaR., & FesceR. (1998). Computer-driven approach to PCR-based differential screening, alternative to differential display. Bioinformatics2, 93–105.
SundermanF.W.Jr., VargheseA.H., KroftovaO.S., Grbac-IvankovicS., KotyzaJ., DattaA.K., DavisM., BalW., & KasprzakK.S. (1996). Characterization of pNiXa, a serpin of Xenopus laevis oocytes and embryos, and its histidine-rich, Ni(II)-binding domain. Molecular Reproduction and Development44, 507–524.
16.
MurataM., GongP., SuzukiK., & KoizumiS. (1999). Differential metal response and regulation of human heavy metal-inducible genes. Journal of Cellular Physiology180, 105–113.
17.
SunH., LiH., HarveyI., & SadlerP.J. (1999). Interaction of bismuth complex with metallothionein. Journal of Biological Chemistry274, 29,094–29,101.
18.
SimpkinsC.O. (2000). Metallothionein in human disease. Cellular and Molecular Biology46, 465–488.
19.
RoesijadiG. (2000). Metal transfer as a mechanism for metallothionein-mediated metal detoxification. Cellular and Molecular Biology46, 393–405.
20.
VasakM., & HaslerD.W. (2000). Metallothioneins: new functional and structural insights. Current Opinion in Chemical Biology4, 177–183.
21.
RodillaV., MilesA.T., JennerW., & HawksworthG.M. (1998). Exposure of cultured human proximal tubular cells to cadmium, mercury, zinc and bismuth: toxicity and metallothionein induction. Chemico-Biological Interactions115, 71–83.
22.
AsahiI., MiuraN., YamabeY., ToyodaH., ImuraN., KoyamaM., & NaganumaA. (1999). PF1070A, a novel and potent inducer of the synthesis of metallothionein. Biochemistry38, 10,415–10,423.
23.
ZelazowskiA.J., GarveyJ.S., & HoescheleJ.D. (1984). In vivo and in vitro binding of platinum to metallothionein. Archives of Biochemistry and Biophysics229, 246–252.
24.
NielsonK.B., AtkinC.L., & WingeD.R. (1985). Distinct metal-binding configurations in metallothionein. Journal of Biological Chemistry260, 5342–5350.
25.
XingB.G., ZhuH.F., WangY., & TangW.X. (2000). Binding properties of an orally active platinum antitumor drug JM216 with metallothionein in vivo.Biometals13, 203–208.
26.
NeuerA., SpandorferS.D., GiraldoP., DieterleS., RosenwaksZ., & WitkinS.S. (2000). The role of heat shock proteins in reproduction. Human Reproduction Update6, 149–159.
27.
MonettiC., VigettiD., PratiM., SabbioniE., BernardiniG., & GornatiR. (2002). Gene expression in Xenopus embryos after methylmercury exposure: a search for molecular biomarkers. Environmental Toxicology and Chemistry21, 2731–2736.
28.
MieleG., MacRaeL., McBrideD., MansonJ., & ClintonM. (1998). Elimination of false positives generated through PCR re-amplification of differential display cDNA. Biotechniques25, 138–144.
29.
MuellerP.W., PriceR.G., & FinnW.F. (1998). New approaches for detecting thresholds of human nephrotoxicity using cadmium as an example. Environmental Health Perspectives106, 227–230.
30.
GardiC., CalzoniP., FerraliM., & ComportiM. (1997). Iron mobilization from crocidolite as enhancer of collagen content in rat lung fibroblasts. Biochemical Pharmacology53, 1659–1665.
31.
RuizI.G., de la TorreP., DiazT., EstebanE., MorillasJ.D., Munoz-YagueT., & Solis-HerruzoJ.A. (2000). Sp family of transcription factors is involved in iron-induced collagen alpha1(I) gene expression. DNA and Cell Biology19, 167–178.
32.
ParkesJ.G., LiuY., SirnaJ.B., & TempletonD.M. (2000). Changes in gene expression with iron loading and chelation in cardiac myocytes and non-myocytic fibroblasts. Journal of Molecular and Cellular Cardiology32, 233–246.
33.
HicksD.G., O'KeefeR.J., ReynoldsK.J., Cory-SlechtaD.A., PuzasJ.E., JudkinsA., & RosierR.N. (1996). Effects of lead on growth plate chondrocyte phenotype. Toxicology and Applied Pharmacology140, 164–172.
34.
LongG.J. (1997). The effect of cadmium on cytosolic free calcium, protein kinase C, and collagen synthesis in rat osteosarcoma (ROS 17/2.8) cells. Toxicology and Applied Pharmacology143, 189–195.
35.
ChambersR.C., LaurentG.J., & Westergren-ThorssonG. (1998). Cadmium inhibits proteoglycan and procollagen production by cultured human lung fibroblasts. American Journal of Respiratory Cell and Molecular Biology19, 498–506.
36.
WangJ.Y., WicklundB.H., GustiloR.B., & TsukayamaD.T. (1997). Prosthetic metals interfere with the functions of human osteoblast cells in vitro.Clinical Orthopaedics and Related Research339, 216–226.
37.
LiaoV.H., & FreedmanJ.H. (1998). Cadmium-regulated genes from the nematode Caenorhabditis elegans. Identification and cloning of new cadmium-responsive genes by differential display. Journal of Biological Chemistry273, 31,962–31,970.
